Menu IR Home IR Home News Releases Events and Presentations Stock Information Stock Quote Interactive Stock Chart Key Ratios Analyst Coverage FAQs Financials and SEC Filings Annual Reports and Proxies Quarterly Financial Reports SEC Filings Corporate Governance Documents and Charters Management Board of Directors Committee Composition Contact the Board Contact Us News Releases Investor Alerts Year All Years 2021 2020 2019 2018 2017 Keywords Go Advanced Search Search Search Headlines Only From To Asset Types Photos Video Audio Documents Events Standard Dec 4, 2019 Immunic, Inc. to Present Data on IMU-856, for the First Time, at the Crohn's and Colitis Foundation's IBD Innovate Conference IMU-856 has the potential to address one of the putative root causes of inflammatory bowel disease without impairing the immune system Nov 25, 2019 Immunic, Inc. to Participate in Investor and Scientific Conferences in December Nov 19, 2019 Immunic, Inc. Expands Board of Directors with Appointment of Biotechnology Executive Barclay A. Phillips Nov 7, 2019 Immunic, Inc. Reports Third Quarter 2019 Financial Results and Highlights Recent Activity Nov 5, 2019 Immunic, Inc. to Participate in Industry and Investor Conferences in November Show 5102550100 per page«1…567891011…15»
